首页> 外文期刊>Current pharmacogenomics >Gene-Nutrient Interaction in Type 2 Diabetes: An Appraisal of the Role of the Peroxisome Proliferator-Activated Receptor Pathway
【24h】

Gene-Nutrient Interaction in Type 2 Diabetes: An Appraisal of the Role of the Peroxisome Proliferator-Activated Receptor Pathway

机译:2型糖尿病中的基因营养相互作用:对过氧化物酶体增殖物激活受体途径的作用的评价。

获取原文
获取原文并翻译 | 示例
           

摘要

Type 2 diabetes mellitus (T2DM), characterized by insulin resistance and beta-cell dysfunction, is a complex, multifactorial disease, which has become a worldwide epidemic in the 21~(st) century. Twin and family studies have revealed a strong genetic component of T2DM, and a number of candidate genes such as the peroxisome proliferator-activated receptor y (PPARy) and CAPN10, have been identified in human populations. Previous studies also indicate that body mass index, dietary factors (e.g. fat/vegetable intake, high/low glycemic-load diet), as well as lifestyle variables (e.g. sedentary behavior, prolonged television viewing) are associated with an increased risk of T2DM. Therefore, the interaction between genetic and dietary/lifestyle factors may play a central role in the pathogenesis of T2DM. In this review, we focus on the PPAR pathway to illustrate how molecular variants of genes belonging to this pathway may respond differently to various dietary signals on the risk of T2DM, because they serve as nutrient sensors. The key molecules involved in this pathway include PPARa, which plays a significant role in the regulation of nutrient metabolism especially fatty acid oxidation, PPARy, which is primarily expressed in adipose tissue where it stimulates adipogenesis and lipogenesis, and PPARy coactivator la (PGC-la), which is involved in regulation of gluconeogenesis Drugs that target PPARy - thiazolidinedione (TZD), have now been widely used in the treatment of T2DM. We'll delineate in detail how genetic variants of molecules in the PPAR pathway may modify the response to TZD in T2DM patients.
机译:2型糖尿病(T2DM)以胰岛素抵抗和β细胞功能障碍为特征,是一种复杂的多因素疾病,在21世纪已成为世界范围的流行病。孪生和家族研究表明,T2DM具有很强的遗传成分,并且在人群中已经发现了许多候选基因,例如过氧化物酶体增殖物激活受体y(PPARy)和CAPN10。先前的研究还表明,体重指数,饮食因素(例如脂肪/蔬菜摄入,高/低血糖负荷饮食)以及生活方式变量(例如久坐行为,长时间看电视)与T2DM风险增加相关。因此,遗传因素与饮食/生活方式因素之间的相互作用可能在T2DM的发病机理中起着核心作用。在这篇综述中,我们将重点放在PPAR途径上,以说明属于该途径的基因的分子变体如何对各种饮食信号引发T2DM的风险做出不同的反应,因为它们可作为营养传感器。参与该途径的关键分子包括PPARa(其在营养代谢特别是脂肪酸氧化的调节中起重要作用),PPARy(主要在脂肪组织中表达,它刺激脂肪生成和脂肪生成)以及PPARy辅助激活剂la(PGC-la ,它参与糖异生的调控。靶向PPARγ的药物-噻唑烷二酮(TZD)现在已广泛用于治疗T2DM。我们将详细描述PPAR途径中分子的遗传变异如何改变T2DM患者对TZD的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号